Baxter International Inc. (BAX)
| Market Cap | 17.27B |
| Revenue (ttm) | 10.64B |
| Net Income (ttm) | -649.00M |
| Shares Out | 510.59M |
| EPS (ttm) | -1.27 |
| PE Ratio | n/a |
| Forward PE | 13.69 |
| Dividend | $0.68 (2.01%) |
| Ex-Dividend Date | Feb 28, 2025 |
| Volume | 5,520,671 |
| Open | 33.51 |
| Previous Close | 33.44 |
| Day's Range | 33.25 - 34.02 |
| 52-Week Range | 28.34 - 44.01 |
| Beta | 0.61 |
| Analysts | Hold |
| Price Target | 38.80 (+14.73%) |
| Earnings Date | Feb 20, 2025 |
About BAX
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technol... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for BAX stock is "Hold." The 12-month stock price forecast is $38.8, which is an increase of 14.73% from the latest price.
News
Baxter International Inc. (BAX) Q4 2024 Earnings Conference Call Transcript
Baxter International Inc. (BAX) Q4 2024 Earnings Conference Call Transcript
Baxter Q4 Earnings Beat Expectations, Issues Strong 2025 Outlook
On Thursday, Baxter International Inc. BAX reported a fourth-quarter 2024 adjusted EPS of 58 cents, beating the management guidance of 50 cents-53 cents and the Wall Street estimate of 52 cents.
Baxter forecasts 2025 profit above estimates on medical device demand; shares rise
Baxter International on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's shares up 7% in premarket trade.
Baxter Reports Fourth-Quarter and Full-Year 2024 Results
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2024, and provided its finan...
Baxter to Present at TD Cowen 45th Annual Health Care Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the TD Cowen 45th Annual Health Care Conference on Wednesday, March 5, 2025. Joel Grade...
Baxter to Present at Raymond James & Associates' 46th Annual Institutional Investors Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James & Associates' 46th Annual Institutional Investors Conference on Monda...
Baxter to Present at Citi - 2025 Medtech & Life Sciences Access Day
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Citi - 2025 Medtech & Life Sciences Access Day on Thursday, February 27, 2025. Joel...
Baxter Declares Quarterly Dividend
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share o...
Baxter CEO José Almeida to retire after near decade-long tenure
Medical products maker Baxter International said on Monday its CEO José Almeida will retire effective immediately, after nearly a decade as the company's top boss.
Baxter Announces CEO Retirement and Appointment of COO
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that José (Joe) E. Almeida, chair, president and chief executive officer (CEO), will re...
Baxter to Host Fourth-Quarter 2024 Financial Results Conference Call for Investors
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2024 financial results on Thursday, February ...
Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025. José (Jo...
Baxter Announces Continued Growth of Pharmaceuticals Portfolio With Five Injectable Product Launches in the U.S.
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product laun...
Baxter resumes dialysis solution production at its hurricane-hit facility
Baxter International said on Thursday it has resumed production on all dialysis solution manufacturing lines at its North Carolina facility after they were impacted by hurricane-related flooding.
Baxter to Present at 7th Annual Evercore HealthCONx Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 7th Annual Evercore HealthCONx Conference on Thursday, December 5, 2024. Joel Grade...
Baxter to Present at Jefferies London Healthcare Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Joel Grade,...
Baxter to Present at Stifel 2024 Healthcare Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Stifel 2024 Healthcare Conference on Monday, November 18, 2024. Joel Grade, Baxter'...
Baxter International Inc. (BAX) Q3 2024 Earnings Call Transcript
Baxter International Inc. (NYSE:BAX) Q3 2024 Earnings Conference Call November 8, 2024 8:30 AM ET Company Participants Clare Trachtman - Senior Vice President, Chief Investor Relations Officer Joe Al...
Baxter cuts annual profit forecast on hurricane impact
Baxter International cut its annual profit forecast on Friday due to a hurricane-related hit to its intravenous solutions facility, sending its shares down 3.3% in premarket trading.
Baxter Reports Third-Quarter 2024 Results
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2024. “Baxter delivered positive performance in the thi...
Baxter restarts IV solutions manufacturing line
Medical device maker Baxter said on Thursday it has restarted the highest-throughput intravenous solutions manufacturing line at its North Carolina facility, which was impacted by hurricane-related fl...
Oneview Healthcare and Baxter International Extend Value-Added Reseller Agreement for Two More Years and Expand the Agreement to include Canada
DUBLIN--(BUSINESS WIRE)--Oneview Healthcare, a leading provider of patient experience solutions is pleased to announce the extension of its strategic relationship with Baxter International Inc. for an...
Baxter expects to restart IV solutions manufacturing line within next week
Medical device maker Baxter said on Thursday it expects to restart the highest-throughput IV solutions manufacturing line at a hurricane-hit plant in North Carolina within the next week.
Baxter to Present at UBS Global Healthcare Conference
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the UBS Global Healthcare Conference on Wednesday, November 13, 2024. Joel Grade, Baxte...